Regional Planning for Extracorporeal Membrane Oxygenation Allocation During Coronavirus Disease 2019Matthew E. Prekker, John L. Hick, Melissa E. Brunsvold et al.|CHEST Journal|2020Cited by 44
Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress SyndromeZachary Bergman, Melissa E. Brunsvold, Ramiro Saavedra-Romero et al.|Surgical Infections|2021Cited by 26
Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease: VENT-AVOID Trial – A Randomized Clinical TrialAbhijit Duggal, Nicholas S. Hill, Steven A. Conrad et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 22
The Use of Venovenous Extracorporeal Membrane Oxygenation in COVID-19 Infection: One Region’s Comprehensive ExperienceZachary Bergman, Melissa E. Brunsvold, Jillian K. Wothe et al.|ASAIO Journal|2021Cited by 14
Use of Venovenous Extracorporeal Membrane Oxygenation in Patients With Acute Respiratory Distress Syndrome Caused by Fungal PneumoniaBridget Dillon, Melissa E. Brunsvold, Jillian K. Wothe et al.|Surgical Infections|2023Cited by 4